Literature DB >> 21704379

Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis.

Parul Kulshreshtha1, Rakesh Bhatnagar.   

Abstract

Bacillus anthracis overwhelms its victims by way of two toxins, namely edema toxin and lethal toxin. Lethal toxin is formed by the combination of protective antigen with lethal factor while edema toxin is formed by the combination of Protective Antigen with edema factor. Overlapping regions between edema factor and lethal factor have been reported in past. For the first time, this study reports characterization of a bispecific monoclonal antibody (mAb), H10, which showed high affinity interaction with both edema factor and lethal factor of B. anthracis. H10 mAb not only neutralized the adenylate cyclase activity of edema toxin but it could also neutralize the cytotoxic activity of lethal toxin. Passive immunization with this antibody gave 100% protection to mice from in vivo challenge with lethal toxin and edema toxin. The results of this study suggest future application of this bispecific monoclonal antibody as passive immunization prophylactics in cases of B. anthracis exposure and infection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704379     DOI: 10.1016/j.molimm.2011.05.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.

Authors:  Lernik Ohanjanian; Kenneth E Remy; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2015-04-28       Impact factor: 6.206

2.  Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.

Authors:  Eric K Dumas; Timothy Gross; Jason Larabee; Lance Pate; Hannah Cuthbertson; Sue Charlton; Bassam Hallis; Renata J M Engler; Limone C Collins; Christina E Spooner; Hua Chen; Jimmy Ballard; Judith A James; A Darise Farris
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

3.  Structure-based redesign of an edema toxin inhibitor.

Authors:  Deliang Chen; Lili Ma; John J Kanalas; Jian Gao; Jennifer Pawlik; Maria Estrella Jimenez; Mary A Walter; Johnny W Peterson; Scott R Gilbertson; Catherine H Schein
Journal:  Bioorg Med Chem       Date:  2011-11-16       Impact factor: 3.641

4.  Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.

Authors:  Mary Ann Pohl; Johanna Rivera; Antonio Nakouzi; Siu-Kei Chow; Arturo Casadevall
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

5.  Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.

Authors:  Philippe Thullier; Arnaud Avril; Jacques Mathieu; Christian K Behrens; Jean-Luc Pellequer; Thibaut Pelat
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 6.  Antibodies against anthrax: mechanisms of action and clinical applications.

Authors:  Jeffrey W Froude; Philippe Thullier; Thibaut Pelat
Journal:  Toxins (Basel)       Date:  2011-11-16       Impact factor: 4.546

Review 7.  Monoclonal antibodies and toxins--a perspective on function and isotype.

Authors:  Siu-Kei Chow; Arturo Casadevall
Journal:  Toxins (Basel)       Date:  2012-06-11       Impact factor: 4.546

8.  A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.

Authors:  Andrea Zito; Carla Bromuro; Giorgia Mandili; Paola Chiani; Alberto L Horenstein; Fabio Malavasi; Roberto Cauda; Antonio Cassone; Antonella Torosantucci
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

Review 9.  Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.

Authors:  Martin Göttle; Stefan Dove; Roland Seifert
Journal:  Toxins (Basel)       Date:  2012-07-06       Impact factor: 4.546

10.  A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.

Authors:  Guipeng Ding; Ximin Chen; Jin Zhu; Nicholas S Duesbery; Xunjia Cheng; Brian Cao
Journal:  Clin Dev Immunol       Date:  2013-06-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.